| Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements R Mikolajczak, S Huclier-Markai, C Alliot, F Haddad, D Szikra, V Forgacs, ... EJNMMI Radiopharmacy and Chemistry 6 (1), 19, 2021 | 50 | 2021 |
| Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in … T Maina, MW Konijnenberg, P KolencPeitl, P Garnuszek, BA Nock, ... European Journal of Pharmaceutical Sciences 91, 236-242, 2016 | 46 | 2016 |
| Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation E Koumarianou, R Mikołajczak, D Pawlak, X Zikos, P Bouziotis, ... Nuclear medicine and biology 36 (6), 591-603, 2009 | 42 | 2009 |
| Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples P Kolenc Peitl, C Rangger, P Garnuszek, R Mikolajczak, ... Journal of Labelled Compounds and Radiopharmaceuticals 62 (10), 673-683, 2019 | 36 | 2019 |
| From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial D Pawlak, C Rangger, PK Peitl, P Garnuszek, M Maurin, L Ihli, M Kroselj, ... European Journal of Pharmaceutical Sciences 85, 1-9, 2016 | 36 | 2016 |
| Targeted delivery of anti-cancer growth inhibitory peptides derived from human α-fetoprotein: review of an International Multi-Center Collaborative Study GJ Mizejewski, M Mirowski, P Garnuszek, M Maurin, BD Cohen, ... Journal of drug targeting 18 (8), 575-588, 2010 | 36 | 2010 |
| The platinum complexes with histamine: Pt (II)(Hist) Cl2, Pt (II)(Iodo-Hist) Cl2 and Pt (IV)(Hist) 2Cl2 WP Ozimiński, P Garnuszek, E Bednarek, JC Dobrowolski Inorganica chimica acta 360 (6), 1902-1914, 2007 | 34 | 2007 |
| Evaluation of a freeze-dried kit for EDTMP-based bone-seeking radiopharmaceuticals P Garnuszek, D Pawlak, I Licińska, A Kamińska Applied radiation and isotopes 58 (4), 481-488, 2003 | 34 | 2003 |
| Biological investigation of the platinum (II)-[∗ I] iodohistamine complexes of potential synergistic anti-cancer activity P Garnuszek, I Liciánska, JS Skierski, M Koronkiewicz, M Mirowski, ... Nuclear medicine and biology 29 (2), 169-175, 2002 | 30 | 2002 |
| Synthesis and characterisation of platinum (II) complexes with histamine and iodohistamine P Garnuszek, JK Maurin, J Witowska-Jarosz, B Ptasiewicz-Bąk Inorganica Chimica Acta 338, 119-126, 2002 | 22 | 2002 |
| A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid … PA Erba, H Maecke, R Mikolajczak, C Decristoforo, K Zaletel, ... Polish archives of internal medicine 128 (12), 791, 2018 | 20 | 2018 |
| Radiopharmaceuticals in cardiology R Mikołajczak, P Garnuszek Nuclear Medicine Review 15 (1), 39-45, 2012 | 18 | 2012 |
| Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide U Karczmarczyk, P Garnuszek, M Maurin, V Di Gialleonardo, F Galli, ... Nuclear medicine and biology 37 (7), 795-803, 2010 | 18 | 2010 |
| Standardization of Procedures for the Preparation of 177Lu-and 90Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation W Wojdowska, U Karczmarczyk, M Maurin, P Garnuszek, R Mikolajczak Current Radiopharmaceuticals 8 (1), 62-68, 2015 | 16 | 2015 |
| Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients M Opalinska, T Stompor, D Pach, R Mikolajczak, D Fedak, M Krzanowski, ... European journal of nuclear medicine and molecular imaging 39, 673-682, 2012 | 14 | 2012 |
| The synthesis, radioiodination and preliminary biological study of the new carboxylic derivatives of dithizone P Garnuszek, I Liciñska, P Fiedor, AP Mazurek Applied radiation and isotopes 49 (12), 1563-1571, 1998 | 14 | 1998 |
| Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor PFJ Lipiński, P Garnuszek, M Maurin, R Stoll, N Metzler-Nolte, ... EJNMMI research 8, 1-10, 2018 | 13 | 2018 |
| Oxidation of methionine—is it limiting the diagnostic properties of 99mTc-labeled Exendin-4, a Glucagon-Like Peptide-1 receptor agonist? B Janota, U Karczmarczyk, E Laszuk, P Garnuszek, R Mikołajczak Nuclear Medicine Review 19 (2), 104-110, 2016 | 13 | 2016 |
| The radiometal makes a difference. Synthesis and preliminary characterisation of DOTA-minigastrin analogue complexes with Ga, Lu and Y M Maurin, P Garnuszek, P Baran, D Pawlak, R Mikołajczak Nuclear Medicine Review 18 (2), 51-55, 2015 | 12 | 2015 |
| Selection of the First 99mTc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation—Preclinical Assessment of Two Optimized Candidates M Fani, V Weingaertner, P Kolenc Peitl, R Mansi, RH Gaonkar, ... Pharmaceuticals 14 (01), 19, 2020 | 11 | 2020 |
